Xue et al. showed that protein 4.1B could bind EGFR and inhibit EGFR function through the EGFR/MAPK/ERK1/2 pathway, thereby regulating the development and progression of gastric cancer [57]. This evidence concerns the gene EGFR and gastric cancer.